⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL177576 | 0.82 | — | — | |
| SCHEMBL2067545 | 0.78 | LMNA (0.41) | — | |
| SCHEMBL3525467 | 0.75 | — | — | |
| SCHEMBL2818903 | 0.75 | TSHR (0.35) | — | |
| SCHEMBL4679491 | 0.74 | — | — | |
| SCHEMBL2565204 | 0.73 | — | — | |
| SCHEMBL646821 | 0.72 | — | — | |
| SCHEMBL4277857 | 0.71 | CHRNB2 (0.31) | — | |
| SCHEMBL15016057 | 0.69 | — | — | |
| SCHEMBL18043744 | 0.69 | SLC6A4 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3887371-B1 | ARYL COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | HOFFMANN LA ROCHE (CH) | 2023-02-22 | — | — | EP | claimed |
| US-20210309658-A1 | ARYL COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | HOFFMANN-LA ROCHE INC. (US) | 2021-10-07 | — | — | US | claimed |
| EP-3887371-A1 | ARYL COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | F. Hoffmann-La Roche AG (CH) | 2021-10-06 | — | — | EP | claimed |
| CN-113166144-A | Aryl compounds for the treatment and prevention of bacterial infections | 豪夫迈·罗氏有限公司 | 2021-07-23 | — | — | CN | claimed |
| WO-2020109191-A1 | ARYL COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | F. HOFFMANN-LA ROCHE AG (CH) | 2020-06-04 | — | — | WO | claimed |
| US-5811081-A | Use of hydroxybenzotriazoles for enhancing the sun protection factor of cellulosic fibre materials | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-09-22 | — | — | US | claimed |
| EP-0708197-A2 | Utilisation of hydroxybenztriazoles for increasing the sun-ray filter index of fibrous cellulosic materials | CIBA-GEIGY AG (CH) | 1996-04-24 | — | — | EP | claimed |
| EP-0516069-A1 | Leukotriene B4 antagonist | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1992-12-02 | — | — | EP | claimed |
| EP-3887371-B1 | ARYL COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | HOFFMANN LA ROCHE (CH) | 2023-02-22 | — | — | EP | disclosed |
| US-20210309658-A1 | ARYL COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | HOFFMANN-LA ROCHE INC. (US) | 2021-10-07 | — | — | US | disclosed |
| EP-3887371-A1 | ARYL COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | F. Hoffmann-La Roche AG (CH) | 2021-10-06 | — | — | EP | disclosed |
| CN-113166144-A | Aryl compounds for the treatment and prevention of bacterial infections | 豪夫迈·罗氏有限公司 | 2021-07-23 | — | — | CN | disclosed |
| WO-2020109191-A1 | ARYL COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | F. HOFFMANN-LA ROCHE AG (CH) | 2020-06-04 | — | — | WO | disclosed |
| EP-3078662-A1 | PYRIDIN-2-YL-AMINO-1,2,4-THIADIAZOLE DERIVATIVES AS GLUCOKINASE ACTIVATORS FOR THE TREATMENT OF DIABETES MELLITUS | Array Biopharma, Inc. (US) | 2016-10-12 | — | — | EP | disclosed |
| US-20060241110-A1 | Compounds, compositions, and methods | CYTOKINETICS, INCORPORATED | 2006-10-26 | — | — | US | disclosed |
| US-20050159416-A1 | Compounds, compositions and methods | CYTOKINETICS, INCORPORATED | 2005-07-21 | — | — | US | disclosed |
| US-5811081-A | Use of hydroxybenzotriazoles for enhancing the sun protection factor of cellulosic fibre materials | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-09-22 | — | — | US | disclosed |
| EP-0708197-A2 | Utilisation of hydroxybenztriazoles for increasing the sun-ray filter index of fibrous cellulosic materials | CIBA-GEIGY AG (CH) | 1996-04-24 | — | — | EP | disclosed |
| US-5225422-A | Antiallergens, antiinflammatory agents | SUMITOMO PHARMACEUTICALS CO., LTD. (JP) | 1993-07-06 | — | — | US | disclosed |
| EP-0516069-A1 | Leukotriene B4 antagonist | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1992-12-02 | — | — | EP | disclosed |